封面
市场调查报告书
商品编码
1413879

生物製造中的病毒检测和定量市场:按产品类型、技术、应用和最终用户划分 - 2024-2030 年全球预测

Biomanufacturing Viral Detection & Quantification Market by Offering Type (Consumables, Instruments, Services), Technology (Enzyme-Linked Immunosorbent Assay, Flow Cytometry, Plaque Assay), Application, End User - Global Forecast 2024-2030

出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

生物製造领域的病毒检测和定量市场规模预计到2023年为26.7亿美元,2024年达到28.9亿美元,2030年达到47.1亿美元,复合年增长率为8.40%。

生物製造中病毒检测和定量的全球市场

主要市场统计
基准年[2023] 26.7亿美元
预测年份 [2024] 28.9亿美元
预测年份 [2030] 47.1亿美元
复合年增长率(%) 8.4%
生物製造病毒检测与定量市场-IMG1

生物製药製造市场中的病毒检测和定量涵盖涉及生物製药製造流程中病毒污染物识别和测量的技术、服务和解决方案的开发、生产和商业化的行业和部门。增加对生物製药研究和开发的投资正在促进市场成长。在备受瞩目的污染事件后,人们对产品安全的认识不断提高,加上严格的监管要求的出台,正在推动生物製造市场中病毒检测和定量的业务成长。然而,高昂的测试成本和复杂的监管核准流程可能会对中小企业造成进入壁垒,影响市场竞争。此外,需要高技能人员执行和解释复杂的检测也增加了市场空间的操作挑战。此外,新型病毒灭活方法和即时病毒检测技术的开拓将为市场带来创新机会。跨不同平台的检测标准化的研究倡议为市场提供了巨大的成长潜力。

区域洞察

美国和加拿大是生物製造病毒检测和定量的关键市场。这些美洲地区的特点是先进的医疗保健系统、较高的人均医疗费用以及严格的生技药品安全性和有效性法规环境。在欧洲国家,生物製造业不断进步,注重创新、品质和安全。该欧洲、中东和非洲地区的客户热衷于采用符合欧盟严格法规结构的尖端病毒检测技术。由于医疗保健投资增加和生物製药需求不断增长,中东地区呈现出有希望的成长。由于消费者对本地生产和进口生技药品品质保证的需求不断增加,中东地区的病毒检测和定量市场仍处于起步阶段。由于强劲的经济成长、不断增长的医疗支出和不断扩大的技术采用,亚太地区的生物製造领域正在经历快速成长。亚太地区快速成长的疫苗生产产业和出口市场推动了对病毒检测和定量解决方案的需求,客户更喜欢经济高效且可靠的技术。

FPNV定位矩阵

FPNV定位矩阵对于评估生物製造市场中的病毒检测和定量至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。

市场占有率分析

市场占有率分析是一种综合工具,可以对生物製造市场病毒检测和定量供应商的现状进行深入而深入的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该行业竞争特征的宝贵考察,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,从而在市场上获得竞争优势。

本报告在以下方面提供了宝贵的见解:

1-市场渗透率:提供有关主要企业所服务的市场的全面资讯。

2-市场开拓:我们深入研究利润丰厚的新兴市场,并分析它们在成熟细分市场中的渗透率。

3- 市场多元化:提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新:提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题:

1-生物製造中病毒检测和定量市场的市场规模和预测是多少?

2-在生物製造市场病毒检测和定量的预测期内,需要考虑投资哪些产品、细分市场、应用和领域?

3-生物製造中病毒检测和定量市场的技术趋势和法律规范是什么?

4-生物製造市场病毒检测和定量主要厂商的市场占有率是多少?

5-进入生物製造病毒检测和定量市场的适当型态和策略手段是什么?

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 病毒性疾病发生率不断增加,需要增强检测技术
      • 药物开发和製造流程的指数级投资
      • 对便携式护理点关键测试的需求不断增长
    • 抑制因素
      • 缺乏熟练人员及量化设备成本高
    • 机会
      • 病毒检测和定量方法的快速进步
      • 重点关注病毒污染物的环境监测
    • 任务
      • 与病毒量分离相关的技术困难
  • 市场区隔分析
    • 产品类型:高精度耗材升级
    • 技术:改进PCR技术的采用以实现高特异性
    • 应用:在疫苗和治疗药物生产的广泛应用
    • 最终用户:CRO 和 CDMO 越来越多地采用病毒定量
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章按产品类型分類的生物製造市场中的病毒检测和定量

  • 消耗品
    • 配件
    • 套件和检测
  • 装置
  • 服务

第七章生物製造中的病毒检测和定量市场:按技术分类

  • 酵素免疫分析法
  • 流式细胞仪
  • 斑块测定
  • 聚合酶炼式反应

第八章生物製造中的病毒检测和定量市场:按应用分类

  • 血液和血液製品的製造
  • 细胞和基因治疗产品的製造
  • 干细胞产品的製造
  • 纸巾及纸巾产品的製造
  • 疫苗和治疗药物的製造

第九章生物製造中的病毒检测和定量市场:按最终用户分类

  • CRO 和 CDMO
  • 生命科学公司
  • 测试实验室

第十章美洲生物製造的病毒检测与定量市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区生物製造中的病毒检测与定量市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲生物製造领域的病毒检测和定量市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析:主要企业
  • 主要企业竞争情境分析
    • 新产品发布和功能增强
    • 奖项/奖励/扩展

第14章竞争产品组合

  • 主要公司简介
    • Agilent Technologies, Inc.
    • BASF SE
    • Becton, Dickinson and Company
    • Bio-Rad Laboratories, Inc.
    • bioMerieux SA
    • Charles River Laboratories
    • Danaher Corporation
    • Genscript Biotech Corporation
    • Hamilton Company
    • Illumina, Inc.
    • LG Chem, Ltd.
    • Lonza Group Ltd.
    • Merck KGaA
    • New England Biolabs
    • Norgen Biotek Corp.
    • Oxford Nanopore Technologies PLC
    • PerkinElmer, Inc.
    • Promega Corporation
    • QIAGEN NV
    • Recipharm AB
    • Sartorius AG
    • Shimadzu Corporation
    • Takara Bio Inc.
    • Thermo Fisher Scientific Inc.
    • Thomas Scientific LLC
    • Zymo Research Corporation
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-5C6F41F5AFA5

[194 Pages Report] The Biomanufacturing Viral Detection & Quantification Market size was estimated at USD 2.67 billion in 2023 and expected to reach USD 2.89 billion in 2024, at a CAGR 8.40% to reach USD 4.71 billion by 2030.

Global Biomanufacturing Viral Detection & Quantification Market

KEY MARKET STATISTICS
Base Year [2023] USD 2.67 billion
Estimated Year [2024] USD 2.89 billion
Forecast Year [2030] USD 4.71 billion
CAGR (%) 8.4%
Biomanufacturing Viral Detection & Quantification Market - IMG1

The biomanufacturing viral detection and quantification market encompasses the industries and sectors involved in developing, producing, and commercializing technologies, services, and solutions for identifying and measuring viral contaminants in the biomanufacturing process. The increased investments in biopharmaceutical R&D is contributing to the market growth. The heightened awareness of product safety following high-profile contamination cases and the introduction of stringent regulatory requirements drive the business growth in the biomanufacturing viral detection & quantification market. However, the high costs of testing and the complexity of regulatory approval processes may create barriers to entry for smaller companies, affecting market competitiveness. The need for highly skilled individuals to perform and interpret complex assays adds to market space operational challenges. Moreover, developing novel viral inactivation methods and real-time viral detection technologies creates innovative opportunities in the market. The research initiative, which is directed towards standardizing assays across different platforms, creates significant growth potential in the market.

Regional Insights

In the Americas, the United States and Canada are pivotal markets for biomanufacturing viral detection and quantification. These Americas region is characterized by advanced healthcare systems, high per capita healthcare spending, and stringent regulatory environments that govern the safety and efficacy of biologics. In the European countries, the biomanufacturing sector is advanced with a strong emphasis on innovation, quality, and safety. Customers in this EMEA region are keen on adopting state-of-the-art viral detection technologies that align with the stringent EU regulatory frameworks. The Middle East shows promising growth with increased healthcare investments and a rising demand for biopharmaceuticals. The market for viral detection and quantification in the Middle East region is nascent, with a growing consumer need for quality assurance in locally produced and imported biologics. The Asia Pacific region is experiencing surge in the biomanufacturing domain, due to robust economic growth, increasing healthcare expenditures, and growing technological adoption. The demand for viral detection and quantification solutions is driven by the burgeoning vaccine production sector and export market in the APAC region, with customers showing a preference for cost-effective yet reliable technologies.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Biomanufacturing Viral Detection & Quantification Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Biomanufacturing Viral Detection & Quantification Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Biomanufacturing Viral Detection & Quantification Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., BASF SE, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., bioMerieux SA, Charles River Laboratories, Danaher Corporation, Genscript Biotech Corporation, Hamilton Company, Illumina, Inc., LG Chem, Ltd., Lonza Group Ltd., Merck KGaA, New England Biolabs, Norgen Biotek Corp., Oxford Nanopore Technologies PLC, PerkinElmer, Inc., Promega Corporation, QIAGEN N.V., Recipharm AB, Sartorius AG, Shimadzu Corporation, Takara Bio Inc., Thermo Fisher Scientific Inc., Thomas Scientific LLC, and Zymo Research Corporation.

Market Segmentation & Coverage

This research report categorizes the Biomanufacturing Viral Detection & Quantification Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Offering Type
    • Consumables
      • Accessories
      • Kits & Assays
    • Instruments
    • Services
  • Technology
    • Enzyme-Linked Immunosorbent Assay
    • Flow Cytometry
    • Plaque Assay
    • Polymerase Chain Reaction
  • Application
    • Blood & Blood Products Manufacturing
    • Cellular & Gene Therapy Products Manufacturing
    • Stem Cell Products Manufacturing
    • Tissue & Tissue Products Manufacturing
    • Vaccines & Therapeutics Manufacturing
  • End User
    • CROs & CDMOs
    • Life Science Companies
    • Testing Laboratories
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Biomanufacturing Viral Detection & Quantification Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Biomanufacturing Viral Detection & Quantification Market?

3. What are the technology trends and regulatory frameworks in the Biomanufacturing Viral Detection & Quantification Market?

4. What is the market share of the leading vendors in the Biomanufacturing Viral Detection & Quantification Market?

5. Which modes and strategic moves are suitable for entering the Biomanufacturing Viral Detection & Quantification Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Biomanufacturing Viral Detection & Quantification Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing incidence of viral diseases and need for enhanced detection techniques
      • 5.1.1.2. Exponential investments in drug development and manufacturing processes
      • 5.1.1.3. Growing demand for portable and point-of-care vital testing
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of skilled personnel and high cost of quantification devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Rapid advancements in viral testing and quantification methods
      • 5.1.3.2. Emphasis on environmental monitoring of viral contaminants
    • 5.1.4. Challenges
      • 5.1.4.1. Technical difficulties associated with the isolation of viral load
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Offering Type: Advances in consumables for high accuracy
    • 5.2.2. Technology: Improved adoption of PCR technique for high specificity
    • 5.2.3. Application: Surging applications in vaccines & therapeutics manufacturing
    • 5.2.4. End User: Rising adoption from CROs and CDMOs for viral quantification
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Biomanufacturing Viral Detection & Quantification Market, by Offering Type

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.3.1. Accessories
    • 6.3.2. Kits & Assays
  • 6.3. Instruments
  • 6.4. Services

7. Biomanufacturing Viral Detection & Quantification Market, by Technology

  • 7.1. Introduction
  • 7.2. Enzyme-Linked Immunosorbent Assay
  • 7.3. Flow Cytometry
  • 7.4. Plaque Assay
  • 7.5. Polymerase Chain Reaction

8. Biomanufacturing Viral Detection & Quantification Market, by Application

  • 8.1. Introduction
  • 8.2. Blood & Blood Products Manufacturing
  • 8.3. Cellular & Gene Therapy Products Manufacturing
  • 8.4. Stem Cell Products Manufacturing
  • 8.5. Tissue & Tissue Products Manufacturing
  • 8.6. Vaccines & Therapeutics Manufacturing

9. Biomanufacturing Viral Detection & Quantification Market, by End User

  • 9.1. Introduction
  • 9.2. CROs & CDMOs
  • 9.3. Life Science Companies
  • 9.4. Testing Laboratories

10. Americas Biomanufacturing Viral Detection & Quantification Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Biomanufacturing Viral Detection & Quantification Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Biomanufacturing Viral Detection & Quantification Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player
    • 13.3.1. New Product Launch & Enhancement
      • 13.3.1.1. Launch of DNAllergen Real-time PCR Kits for the Reliable Detection Of Target Allergen Sequences
      • 13.3.1.2. Virax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test Kit
    • 13.3.2. Award, Recognition, & Expansion
      • 13.3.2.1. New BGI Genomics Fluorescent RT-PCR Kit Approved for COVID-19, Influenza A & B Detection in Australia

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. Agilent Technologies, Inc.
    • 14.1.2. BASF SE
    • 14.1.3. Becton, Dickinson and Company
    • 14.1.4. Bio-Rad Laboratories, Inc.
    • 14.1.5. bioMerieux SA
    • 14.1.6. Charles River Laboratories
    • 14.1.7. Danaher Corporation
    • 14.1.8. Genscript Biotech Corporation
    • 14.1.9. Hamilton Company
    • 14.1.10. Illumina, Inc.
    • 14.1.11. LG Chem, Ltd.
    • 14.1.12. Lonza Group Ltd.
    • 14.1.13. Merck KGaA
    • 14.1.14. New England Biolabs
    • 14.1.15. Norgen Biotek Corp.
    • 14.1.16. Oxford Nanopore Technologies PLC
    • 14.1.17. PerkinElmer, Inc.
    • 14.1.18. Promega Corporation
    • 14.1.19. QIAGEN N.V.
    • 14.1.20. Recipharm AB
    • 14.1.21. Sartorius AG
    • 14.1.22. Shimadzu Corporation
    • 14.1.23. Takara Bio Inc.
    • 14.1.24. Thermo Fisher Scientific Inc.
    • 14.1.25. Thomas Scientific LLC
    • 14.1.26. Zymo Research Corporation
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET RESEARCH PROCESS
  • FIGURE 2. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2023 VS 2030
  • FIGURE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET DYNAMICS
  • FIGURE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2030 (%)
  • FIGURE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
  • FIGURE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2030 (%)
  • FIGURE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 8. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY KITS & ASSAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 13. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY ENZYME-LINKED IMMUNOSORBENT ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY FLOW CYTOMETRY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY PLAQUE ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY BLOOD & BLOOD PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CELLULAR & GENE THERAPY PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STEM CELL PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TISSUE & TISSUE PRODUCTS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY VACCINES & THERAPEUTICS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 24. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CROS & CDMOS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY LIFE SCIENCE COMPANIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TESTING LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY OFFERING TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
  • TABLE 236. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 237. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 238. BIOMANUFACTURING VIRAL DETECTION & QUANTIFICATION MARKET LICENSE & PRICING